the point is rejuvenation

the point is rejuvenation

Changing how aging eyes see the world

Changing how aging eyes see the world

Shaping the future of eye care

Partnering with eye care professionals to redefine what’s possible

Tenpoint branded circle

At Tenpoint Therapeutics, we’re rejuvenating vision for the aging eye. By understanding real-world needs and partnering with eye care professionals, we’re setting a new standard for presbyopia care.

Presbyopia is just the beginning

Presbyopia is a gradual loss of near visual acuity that typically begins around age 40 and significantly affects aging eyes and quality of life.1,2

We’re prioritizing:

Functional near visionto address real-world needs

ECP at computer

Functional near visionto address real-world needs

Presbyopia affects people daily, making it difficult to read and manage work or social activities with just eyeglasses.2

Duration of effectto meet the most demanding part of the day

Clock with hour and minute hand

Duration of effectto meet the most demanding part of the day

Presbyopia patients may benefit from a 
solution that provides near-vision improvement throughout the day, without significant limitations.3

Tolerability profileto maintain long-term use

Eye drop into eye

Tolerability profileto maintain long-term use

People with presbyopia need near-vision treatments that support long-term daily use.1

Presbyopia patient looking down
Person with presbyopia reading at home
the point is

Tenpoint Therapeutics is transforming the treatment landscape by confronting the unmet needs that millions of patients face in maintaining clear near vision as they age.

Tenpoint Therapeutics News and Events

Tenpoint Therapeutics Announces FDA Acceptance of New Drug Application for BRIMOCHOL PF for the Treatment of Presbyopia

Read more

Tenpoint Therapeutics Ltd. Appoints Melissa Epperly as Chief Financial Officer

Read more

Tenpoint Therapeutics Ltd. to Participate at Citi Biotech Private Access Day

Read more

References: 1. Katz JA, Karpecki PM, Dorca A, et al. Presbyopia—a review of current treatment options and emerging therapies. Clin Ophthalmol. 2021;15:2167-2178. 2. Mancil GL, Baily IL, Brookman KE, et al. Optometric clinical practice guideline: care of the patient with presbyopia. American Optometric Association; 2011.
3. Grzybowski A, Kapitanovaite L, Zemaitiene R. An updated systematic review of pharmacological treatments for presbyopia. Adv Ophthalmol Pract Res. 2024;4(4):220-225.

Tenpoint branded circle

You are now leaving tenpointtherapeutics.com.
Are you sure you want to continue?